Alvogen Lux Holdings Increases Stake in Alvotech with Share Acquisition

Alvogen Lux Holdings has acquired 210,000 shares in Alvotech, as reported to Luxembourg’s CSSF.

Acquisition Announcement

A formal press release has been issued regarding a filing with the Luxembourg Commission de Surveillance du Secteur Financier (CSSF). It confirms that Alvogen Lux Holdings S.ár.l., the second-largest shareholder in Alvotech, has purchased 210,000 shares at ISK 1,277.38 each. The ownership structure of Alvogen Lux Holdings includes CVC as the largest shareholder with 40%, followed by Aztiq with 30%, and Temasek with 20%.

Potential Benefits

• This acquisition highlights Alvogen Lux Holdings’ strong confidence in Alvotech, reinforcing its position in the market.
• The backing by notable shareholders such as CVC, Aztiq, and Temasek offers a robust financial foundation for Alvotech.

Potential Concerns

• There may be worries about insider trading or the transparency of key management acquiring substantial shares, which could raise red flags.
• The heavy reliance on major investors like CVC, Aztiq, and Temasek might suggest a lack of independence within Alvogen Lux Holdings, potentially affecting investor confidence.

Frequently Asked Questions

What recent acquisition did Alvogen Lux Holdings make?

Alvogen Lux Holdings acquired 210,000 shares in Alvotech at ISK 1,277.38 each.

Who are the largest shareholders of Alvogen Lux Holdings?

The major shareholders in Alvogen Lux Holdings include CVC (40%), Aztiq (30%), and Temasek (20%).

Which regulatory body received notification of the transactions?

The Luxembourg Commission de Surveillance du Secteur Financier (CSSF) was notified of the transactions.

How many shares were acquired by Alvogen Lux Holdings?

A total of 210,000 shares in Alvotech were acquired by Alvogen Lux Holdings.

What was the price per share for the acquisition of Alvotech?

The acquisition price per share for Alvotech was ISK 1,277.38.

Hedge Fund Activity for $ALVO

Recent data shows that 29 institutional investors added shares of $ALVO to their portfolios, while 14 decreased their holdings in the latest quarter.

The following are some significant recent activities:

• VANGUARD GROUP INC added 995,538 shares (+31.1%) in Q1 2025, valued at approximately $9,626,852.
• OAKTREE CAPITAL MANAGEMENT LP reduced holdings by 606,322 shares (-23.9%) in Q4 2024, with an estimated value of $8,021,640.
• POINTSTATE CAPITAL LP increased their stake by 484,826 shares (+64.1%) in Q4 2024, valued around $6,414,247.
• LEGAL & GENERAL GROUP PLC decreased its holdings by 420,869 shares (-42.2%) in Q4 2024, approximating $5,568,096.
• SCULPTOR CAPITAL LP cut its positions by 338,928 shares (-35.9%) in Q4 2024, worth about $4,484,017.
• MORGAN STANLEY reduced stakes by 257,272 shares (-14.8%) in Q4 2024, valued at approximately $3,403,708.
• MILLENNIUM MANAGEMENT LLC significantly cut holdings by 107,172 shares (-84.7%) in Q4 2024, worth around $1,417,885.

Filing Summary

Attached is the filing with the Luxembourg Commission de Surveillance du Secteur Financier (CSSF), which details the acquisition of 210,000 shares in Alvotech at ISK 1,277.38 by Alvogen Lux Holdings S.ár.l., the second-largest shareholder. The principal shareholders of Alvogen Lux Holdings comprise CVC (40%), Aztiq (30%), and Temasek (20%).